SHERRY FOSTER: Open Payments
NPI 1811612807 · NEWPORT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$500 in 28 payments from 13 companies in 2025. Trend: 2023 $1,046 · 2024 $823 · 2025 $500
Food & beverage: $500
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $142 |
| ABBVIE INC. | 4 | $68 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 1 | $28 |
| Viatris Specialty LLC | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
Products named: Ozempic, Auvelity, CAPLYTA, QULIPTA, TRELEGY ELLIPTA, Rybelsus, VOQUEZNA, YUPELRI.
Industry payments across TN — which companies pay providers there.
